The cell death-inducing activity of the peptide containing Noxa mitochondrial-targeting domain is associated with

Young-Woo Seo1, Ha-Na Woo, Sujan Piya

  • 1Departments of Biochemistry, Anatomy, and Medical Science and Engineering Research Center for Resistant Cells, Chosun University School of Medicine, Gwang-ju, Korea.

Cancer Research
|October 15, 2009
PubMed

Insights

The mitochondrial-targeting domain of Noxa protein induces cell death by increasing calcium levels. This domain shows potent tumor-killing activity in mice, offering a potential new cancer therapy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • DNA damage activates p53, a tumor suppressor protein, influencing cell fate via arrest or death.
  • Noxa, a Bcl-2 family protein, mediates p53-induced apoptosis through mitochondrial dysfunction.
  • The precise mechanism of Noxa-induced mitochondrial dysfunction in response to genotoxic agents remains unclear.

Purpose of the Study:

  • To elucidate the molecular mechanism by which Noxa induces mitochondrial dysfunction and cell death.
  • To investigate the role of the mitochondrial-targeting domain (MTD) of Noxa in cell death.
  • To evaluate the therapeutic potential of Noxa MTD peptides in cancer treatment.

Main Methods:

  • In vitro studies using peptides containing Noxa's MTD.
  • Measurement of cytosolic calcium levels.
  • Analysis of mitochondrial permeability transition pore opening.
  • In vivo studies using tumor-homing motifs conjugated to MTD peptides in mice.

Main Results:

  • The MTD of Noxa functions as a prodeath domain.
  • Noxa MTD peptide induces massive necrosis in vitro, associated with increased cytosolic calcium.
  • MTD peptide release from mitochondria occurs via mitochondrial permeability transition pore opening.
  • MTD peptide-induced cell death is preventable with the calcium chelator BAPTA-AM.
  • MTD peptide demonstrates significant tumor-killing efficacy in mice when linked to tumor-homing motifs.

Conclusions:

  • The Noxa MTD is a critical mediator of genotoxic-induced cell death.
  • Noxa MTD triggers necrosis through calcium dysregulation and mitochondrial pore opening.
  • Noxa MTD peptides represent a promising strategy for developing novel cancer therapeutics.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.